Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
The Ted Rogers Centre for Heart Research is thrilled to welcome Dr. Cedric Manlhiot as the inaugural Rogers Innovator of Cardiovascular Precision Medicine at SickKids. In addition to his role at TRCHR, Dr. Manlhiot will be a Scientist in the Translational Medicine...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Launching in March 2024, emergency department (ED) physicians at the University Health Network (UHN) can now access the Emergency Heart Failure Mortality Risk Grade (EHMRG) calculator within Epic, UHN’s electronic medical record. The EHMRG score estimates the risk of...
Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
3D models of heart failure… stiffened hearts in diabetes…. saving infant lives
After a heart attack, this peptide protects the heart from further injury
Featured Event
Heart Failure Symposium 2024
Virtual Library
Visit our YouTube channel filled with world-class heart failure educational sessions on diverse topics
5th Annual Ted Rogers Centre Heart Failure Symposium
December 4, 2020 @ 9:00 am - December 5, 2020 @ 1:00 pm EST
The fifth annual Ted Rogers Centre Heart Failure Symposium will be held virtually for the first time, Dec. 4-5, 2020. This meeting, which blends clinical innovations with the latest scientific advances, has grown to become Canada’s largest conference on heart failure.
On Friday, December 4th, our research-focused symposium features national and international experts who will explore novel work in precision medicine, genomics, regenerative medicine, immunology, as well as sensor and machine learning technologies.
On Saturday, December 5th, we will hold a symposium for primary care practitioners who manage patients with heart failure, as well as other front-line health-care professionals. Experts will address a range of topics from telemonitoring to genomics to practical considerations for each patient to developing one’s own heart function clinic. Please note that we are seeking Mainpro®accreditation for this program.
Please go to https://tedrogersresearch.ca/symposium/ for more info on program and registration.